Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Waste Management, Inc. (WM) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Waste Management, Inc.Trade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Waste Management, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Waste Management, Inc. trades at $207.95 (market cap $83.98B), while Zimmer Biomet Holdings Inc trades at $88.75 (market cap $16.95B). The key difference: Waste Management, Inc. is far larger — about 5× Zimmer Biomet Holdings Inc's market cap, and Waste Management, Inc. pays the higher dividend (1.8%). Which is the better fit depends on your goals — on Pluang, investors hold Waste Management, Inc. for 130 Days and Zimmer Biomet Holdings Inc for 89 Days on average.

WMZBH
Market Cap
$83.98B$16.95B
Volume
2,182,1802,505,240
Sector
IndustrialsHealth
52-Week High
$246.51$103.98
52-Week Low
$196.77$79.58
Typical Hold Time
130 Days89 Days
Enterprise Value
$106.78B$24.02B
Dividend Yield
1.8%1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Waste Management, Inc.

Waste Management (WM) trades at $207.71, down 0.59% on the day, with a bullish technical signal despite bearish moving averages. The company reported revenue of $25.20 billion in 2025, with net income of $2.71 billion and a net margin of 10.74%. Recent earnings show mixed results, with a miss in Q4 2025 but beats in Q1 and Q2 2026. Analyst consensus is strongly positive with 54.29% buy ratings and no sell recommendations.

WM's outlook remains favorable due to steady revenue growth, strong cash flow, and a resilient business model. Key risks include elevated debt levels and competitive pressures. The stock offers a reliable dividend, with the next payment of $0.95 scheduled for September 25, 2026. Investors should weigh solid fundamentals against debt concerns for long-term holdings.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $88.70, up 0.24% on the day, with a bearish technical outlook but strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady, reaching $8.23B in 2025, while profitability metrics like a 69.87% gross margin and 9.48% net margin reflect operational efficiency. Recent corporate news includes a $0.24 quarterly dividend declaration and leadership promotions aimed at accelerating commercial transformation.

The investment outlook is mixed, with analyst consensus leaning hold (52.38%) but a price target of $103.11 suggesting 16% upside. Key opportunities include sustained earnings beats and strategic initiatives, while risks involve rising debt levels, competitive pressures, and technical bearish signals. The stock's current valuation at a P/E of 21.57 appears reasonable relative to growth prospects, but investors should weigh fundamental strength against near-term technical weakness and macroeconomic headwinds in the healthcare sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

WM

No sentiment data available yet.

ZBH
100% Buy0% Sell
Avg holding period · 89 Days

Top news

Latest headlines on both assets

About Waste Management, Inc.

Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.

Read more on WM →

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH →